全文获取类型
收费全文 | 21917篇 |
免费 | 1500篇 |
国内免费 | 9篇 |
专业分类
23426篇 |
出版年
2024年 | 19篇 |
2023年 | 126篇 |
2022年 | 311篇 |
2021年 | 580篇 |
2020年 | 351篇 |
2019年 | 470篇 |
2018年 | 593篇 |
2017年 | 478篇 |
2016年 | 809篇 |
2015年 | 1215篇 |
2014年 | 1343篇 |
2013年 | 1659篇 |
2012年 | 1948篇 |
2011年 | 1892篇 |
2010年 | 1174篇 |
2009年 | 1016篇 |
2008年 | 1376篇 |
2007年 | 1287篇 |
2006年 | 1179篇 |
2005年 | 1081篇 |
2004年 | 981篇 |
2003年 | 927篇 |
2002年 | 751篇 |
2001年 | 117篇 |
2000年 | 106篇 |
1999年 | 135篇 |
1998年 | 125篇 |
1997年 | 115篇 |
1996年 | 89篇 |
1995年 | 86篇 |
1994年 | 90篇 |
1993年 | 88篇 |
1992年 | 53篇 |
1991年 | 56篇 |
1990年 | 62篇 |
1989年 | 45篇 |
1988年 | 50篇 |
1987年 | 38篇 |
1986年 | 42篇 |
1985年 | 51篇 |
1984年 | 39篇 |
1983年 | 44篇 |
1982年 | 32篇 |
1981年 | 42篇 |
1980年 | 26篇 |
1979年 | 34篇 |
1978年 | 32篇 |
1977年 | 29篇 |
1976年 | 25篇 |
1975年 | 22篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
111.
112.
James G. Pfaus Mark F. Wilkins Nina DiPietro Michael Benibgui Rachel Toledano Anna Rowe Melissa Castro Couch 《Hormones and behavior》2010,58(1):163-176
Drugs of abuse comprise several pharmacological classes, including psychomotor stimulants, such as amphetamine and cocaine, and CNS depressants, such as morphine and alcohol. Few studies have examined the effects of those drugs systematically on human sexual behavior, although substantial clinical and epidemiological literatures suggest that drugs in both classes either inhibit sexual responding or can be “prosexual” in certain situations, thereby increasing the potential of risky sexual activity and the spread of sexually transmitted diseases. This paper reviews original data in rats showing that both classes of drug inhibit or disinhibit sexual behavior depending on the animal's baseline level of sexual responding, hormonal status, whether the drug is given acutely or chronically, and whether the animal has learned to inhibit sexual responding toward nonreceptive partners or in the presence of conditioned olfactory cues that predict sexual nonreward. 相似文献
113.
Christoph Coch Christian Lück Anna Schwickart Bastian Putschli Marcel Renn Tobias H?ller Winfried Barchet Gunther Hartmann Martin Schlee 《PloS one》2013,8(8)
Therapeutic oligonucleotides including siRNA and immunostimulatory ligands of Toll-like receptors (TLR) or RIG-I like helicases (RLH) are a promising novel class of drugs. They are in clinical development for a broad spectrum of applications, e.g. as adjuvants in vaccines and for the immunotherapy of cancer. Species-specific immune activation leading to cytokine release is characteristic for therapeutic oligonucleotides either as an unwanted side effect or intended pharmacology. Reliable in vitro tests designed for therapeutic oligonucleotides are therefore urgently needed in order to predict clinical efficacy and to prevent unexpected harmful effects in clinical development. To serve this purpose, we here established a human whole blood assay (WBA) that is fast and easy to perform. Its response to synthetic TLR ligands (R848: TLR7/8, LPS: TLR4) was on a comparable threshold to the more time consuming peripheral blood mononuclear cell (PBMC) based assay. By contrast, the type I IFN profile provoked by intravenous CpG-DNA (TLR9 ligand) in humans in vivo was more precisely replicated in the WBA than in stimulated PBMC. Since Heparin and EDTA, but not Hirudin, displaced oligonucleotides from their delivery agent, only Hirudin qualified as the anticoagulant to be used in the WBA. The Hirudin WBA exhibited a similar capacity as the PBMC assay to distinguish between TLR7-activating and modified non-stimulatory siRNA sequences. RNA-based immunoactivating TLR7/8- and RIG-I-ligands induced substantial amounts of IFN-α in the Hirudin-WBA dependent on delivery agent used. In conclusion, we present a human Hirudin WBA to determine therapeutic oligonucleotide-induced cytokine release during preclinical development that can readily be performed and offers a close reflection of human cytokine response in vivo. 相似文献
114.
Hemizygosity at the NCF1 gene in patients with Williams-Beuren syndrome decreases their risk of hypertension 下载免费PDF全文
Del Campo M Antonell A Magano LF Muñoz FJ Flores R Bayés M Pérez Jurado LA 《American journal of human genetics》2006,78(4):533-542
Williams-Beuren syndrome (WBS), caused by a heterozygous deletion at 7q11.23, represents a model for studying hypertension, the leading risk factor for mortality worldwide, in a genetically determined disorder. Haploinsufficiency at the elastin gene is known to lead to the vascular stenoses in WBS and is also thought to predispose to hypertension, present in approximately 50% of patients. Detailed clinical and molecular characterization of 96 patients with WBS was performed to explore clinical-molecular correlations. Deletion breakpoints were precisely defined and were found to result in variability at two genes, NCF1 and GTF2IRD2. Hypertension was significantly less prevalent in patients with WBS who had the deletion that included NCF1 (P=.02), a gene coding for the p47(phox) subunit of the NADPH oxidase. Decreased p47(phox) protein levels, decreased superoxide anion production, and lower protein nitrotyrosination were all observed in cell lines from patients hemizygous at NCF1. Our results indicate that the loss of a functional copy of NCF1 protects a proportion of patients with WBS against hypertension, likely through a lifelong reduced angiotensin II-mediated oxidative stress. Therefore, antioxidant therapy that reduces NADPH oxidase activity might have a potential benefit in identifiable patients with WBS in whom serious complications related to hypertension have been reported, as well as in forms of essential hypertension mediated by a similar pathogenic mechanism. 相似文献
115.
tert-Butyl 1-methyl-2-propynyl ether (tBMP) was analyzed for its ability to act as a mechanism-based inactivator of p450 2B4. tBMP inactivated p450 2B4 in a time-, concentration-, and NADPH-dependent manner. Losses in activity occurred with concurrent losses in the reduced CO spectrum and native p450 heme; however, there was a greater loss in activity than could be accounted for by reduced CO spectra or native heme loss. LC/MS analysis demonstrated that the losses in native heme were accompanied by the appearance of two modified hemes with m/z values of 705Da, consistent with tBMP adducted hemes. Both adducts had identical fragmentation patterns when analyzed by LC/MS/MS. The spectra were consistent with a tBMP molecule and an oxygen atom attached to iron-depleted heme. Proton NMR studies suggest that the two modified hemes in p450 2B1 are N-alkylated on pyrrole rings A and D. 相似文献
116.
117.
Marina Giorato Anna Bordin Carla Gemignani Franca Turatello Guido Marcer 《Aerobiologia》2003,19(2):129-131
During recent years a gradual decrease inallergenic airborne pollen concentration hasbeen observed in the monitoring station ofPadua (Italy). Because technical checks of thesampler were not able to explain this trend,the results obtained from two twinpollen-samplers (Lanzoni VPPS 2000), placed twometres apart, were compared.An eight-week sampling was carried out duringthe year 2000 from July to September.Subsequent analysis revealed no statisticallysignificant difference between the dataobtained with the two instruments. On the otherhand, both samplers captured high levels offungal spores. We conclude that the observednegative trend in pollen count is real and notrelated to technical biases. 相似文献
118.
Candussio L Decorti G Crivellato E Granzotto M Rosati A Giraldi T Bartoli F 《Life sciences》2002,71(26):3109-3119
The effect of a chronic treatment with low oral doses of verapamil, a calcium channel blocker commonly employed in cardiovascular therapy, on doxorubicin toxicity, was evaluated in CD1 mice. Verapamil, administered at a dosage corresponding to a typical cardiovascular posology in humans, significantly increased doxorubicin toxicity. In particular the mortality was significantly higher and earlier and histological analysis revealed an increase in the severity of lesions in the liver, kidney and small bowel of verapamil pretreated animals. The pharmacokinetic profiles revealed that verapamil treated group had higher doxorubicin peak plasma and tissue levels and AUCs.This study shows that verapamil, administered at low doses, dramatically increases doxorubicin toxicity, probably through an interaction between the two drugs, both P-glycoprotein substrates, on the protein expressed in normal tissues, and suggests caution in the use of the calcium channel blocker for cardiovascular pathologies in patients who have to be treated with antineoplastic agents, substrates of P-glycoprotein. 相似文献
119.
Lena Hess Verena Moos Arnel A. Lauber Wolfgang Reiter Michael Schuster Natascha Hartl Daniel Lackner Thorina Boenke Anna Koren Paloma M. Guzzardo Brigitte Gundacker Anna Riegler Petra Vician Claudia Miccolo Susanna Leiter Mahesh B. Chandrasekharan Terezia Vcelkova Andrea Tanzer Jun Qi Jun James Bradner Gerald Brosch Markus Hartl Christoph Bock Tilmann Bürckstümmer Stefan Kubicek Susanna Chiocca Srividya Bhaskara Christian Seiser 《PLoS genetics》2022,18(8)
The class I histone deacetylases are essential regulators of cell fate decisions in health and disease. While pan- and class-specific HDAC inhibitors are available, these drugs do not allow a comprehensive understanding of individual HDAC function, or the therapeutic potential of isoform-specific targeting. To systematically compare the impact of individual catalytic functions of HDAC1, HDAC2 and HDAC3, we generated human HAP1 cell lines expressing catalytically inactive HDAC enzymes. Using this genetic toolbox we compare the effect of individual HDAC inhibition with the effects of class I specific inhibitors on cell viability, protein acetylation and gene expression. Individual inactivation of HDAC1 or HDAC2 has only mild effects on cell viability, while HDAC3 inactivation or loss results in DNA damage and apoptosis. Inactivation of HDAC1/HDAC2 led to increased acetylation of components of the COREST co-repressor complex, reduced deacetylase activity associated with this complex and derepression of neuronal genes. HDAC3 controls the acetylation of nuclear hormone receptor associated proteins and the expression of nuclear hormone receptor regulated genes. Acetylation of specific histone acetyltransferases and HDACs is sensitive to inactivation of HDAC1/HDAC2. Over a wide range of assays, we determined that in particular HDAC1 or HDAC2 catalytic inactivation mimics class I specific HDAC inhibitors. Importantly, we further demonstrate that catalytic inactivation of HDAC1 or HDAC2 sensitizes cells to specific cancer drugs. In summary, our systematic study revealed isoform-specific roles of HDAC1/2/3 catalytic functions. We suggest that targeted genetic inactivation of particular isoforms effectively mimics pharmacological HDAC inhibition allowing the identification of relevant HDACs as targets for therapeutic intervention. 相似文献
120.